<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article">
 <front>
  <journal-meta>
   <journal-id journal-id-type="publisher-id">
    ojneph
   </journal-id>
   <journal-title-group>
    <journal-title>
     Open Journal of Nephrology
    </journal-title>
   </journal-title-group>
   <issn pub-type="epub">
    2164-2842
   </issn>
   <issn publication-format="print">
    2164-2869
   </issn>
   <publisher>
    <publisher-name>
     Scientific Research Publishing
    </publisher-name>
   </publisher>
  </journal-meta>
  <article-meta>
   <article-id pub-id-type="doi">
    10.4236/ojneph.2025.153042
   </article-id>
   <article-id pub-id-type="publisher-id">
    ojneph-146216
   </article-id>
   <article-categories>
    <subj-group subj-group-type="heading">
     <subject>
      Articles
     </subject>
    </subj-group>
    <subj-group subj-group-type="Discipline-v2">
     <subject>
      Medicine 
     </subject>
     <subject>
       Healthcare
     </subject>
    </subj-group>
   </article-categories>
   <title-group>
    Complications of Arteriovenous Fistulas in Chronic Hemodialysis Patients in Niamey: Monitoring and Management at the HNABD Nephrology Department
   </title-group>
   <contrib-group>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Zeinabou Maiga Moussa
      </surname>
      <given-names>
       Tondi
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff1"> 
      <sup>1</sup>
     </xref> 
     <xref ref-type="aff" rid="aff2"> 
      <sup>2</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Djibrilla Bonkano
      </surname>
      <given-names>
       Baoua
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff1"> 
      <sup>1</sup>
     </xref> 
     <xref ref-type="aff" rid="aff2"> 
      <sup>2</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Amadou
      </surname>
      <given-names>
       Daouda
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff2"> 
      <sup>2</sup>
     </xref> 
     <xref ref-type="aff" rid="aff3"> 
      <sup>3</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Abdoul Kader Mahamadou
      </surname>
      <given-names>
       Hima
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff3"> 
      <sup>3</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Tidjani Mahamat
      </surname>
      <given-names>
       Hissene
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff2"> 
      <sup>2</sup>
     </xref> 
     <xref ref-type="aff" rid="aff4"> 
      <sup>4</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Moctar Halidou
      </surname>
      <given-names>
       Barkire
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff4"> 
      <sup>4</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Odilon Francis
      </surname>
      <given-names>
       Azon
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff1"> 
      <sup>1</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Rachid
      </surname>
      <given-names>
       Sani
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff2"> 
      <sup>2</sup>
     </xref> 
     <xref ref-type="aff" rid="aff5"> 
      <sup>5</sup>
     </xref>
    </contrib>
   </contrib-group> 
   <aff id="aff1">
    <addr-line>
     aNephrology Department, Amirou Boubacar Diallo National Hospital, Niamey, Niger
    </addr-line> 
   </aff> 
   <aff id="aff2">
    <addr-line>
     aFaculty of Health Sciences, Abdou Moumouni University, Niamey, Niger
    </addr-line> 
   </aff> 
   <aff id="aff3">
    <addr-line>
     aCardiovascular Surgery Department, Niamey General Reference Hospital, Niamey, Niger
    </addr-line> 
   </aff> 
   <aff id="aff4">
    <addr-line>
     aRadiology Department, Niamey General Reference Hospital, Niamey, Niger
    </addr-line> 
   </aff> 
   <aff id="aff5">
    <addr-line>
     aNiamey National Hospital, Niamey, Niger
    </addr-line> 
   </aff> 
   <pub-date pub-type="epub">
    <day>
     25
    </day> 
    <month>
     07
    </month>
    <year>
     2025
    </year>
   </pub-date> 
   <volume>
    15
   </volume> 
   <issue>
    03
   </issue>
   <fpage>
    450
   </fpage>
   <lpage>
    460
   </lpage>
   <history>
    <date date-type="received">
     <day>
      8,
     </day>
     <month>
      August
     </month>
     <year>
      2025
     </year>
    </date>
    <date date-type="published">
     <day>
      27,
     </day>
     <month>
      August
     </month>
     <year>
      2025
     </year> 
    </date> 
    <date date-type="accepted">
     <day>
      27,
     </day>
     <month>
      September
     </month>
     <year>
      2025
     </year> 
    </date>
   </history>
   <permissions>
    <copyright-statement>
     © Copyright 2014 by authors and Scientific Research Publishing Inc. 
    </copyright-statement>
    <copyright-year>
     2014
    </copyright-year>
    <license>
     <license-p>
      This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/
     </license-p>
    </license>
   </permissions>
   <abstract>
    <b>Introduction: </b>The arteriovenous fistula (AVF) is the vascular approach of choice for chronic hemodialysis, due to its durability and low morbidity and mortality. However, it remains exposed to numerous complications that can compromise its proper functioning. 
    <b>Objective: </b>To describe the complications of AVFs and evaluate their management in chronic haemodialysis patients in the nephrology department of the Hôpital National Amirou Boubacar Diallo in Niamey. 
    <b>Methodology: </b>Prospective, descriptive and analytical study conducted from August 2023 to July 2024. Chronic hemodialysis patients with AVF were included. Doppler ultrasound and clinical evaluation were performed. Statistical analysis was performed with SPSS 25.0 and Epi Info 7.2.5.0. 
    <b>Results: </b>Of 126 patients included (mean age: 46 years, sex ratio M/F = 1.93), 42.86% presented with an AVF complication. False aneurysm was the main complication (46.3%), followed by primary failure (22.2%) and thrombosis (18.5%). Management was mainly by medication in 92.3% of cases, but the outcome was favorable in only 38.5%. Several risk factors were identified, including anemia, female gender and prolonged AVF lifespan. 
    <b>Conclusion: </b>Complications of AVFs are frequent in Niamey, with a predominance of false aneurysms. Early detection by Doppler ultrasound and a multidisciplinary approach are essential to improve patient management and prognosis.
   </abstract>
   <kwd-group> 
    <kwd>
     Monitoring and Management
    </kwd> 
    <kwd>
      Complications
    </kwd> 
    <kwd>
      Arteriovenous Fistula
    </kwd> 
    <kwd>
      Chronic Hemodialysis Patients
    </kwd> 
    <kwd>
      Niger
    </kwd>
   </kwd-group>
  </article-meta>
 </front>
 <body>
  <sec id="s1">
   <title>1. Introduction</title>
   <p>End-stage renal disease (ESRD) is a growing public health problem in developing countries, where access to replacement therapy remains limited. Among extrarenal purification modalities, chronic hemodialysis is the most widely used technique in Niger, due to its relative availability and lower cost compared with renal transplantation.</p>
   <p>Efficient implementation of hemodialysis depends on the availability of a reliable vascular access, ensuring sufficient blood flow. The native arteriovenous fistula (AVF) is the approach of choice because of its longevity, low incidence of infection and lower cost than central venous catheters or prosthetic grafts. However, its implementation and maintenance are not without complications, some of them serious, which can compromise continuity of dialysis and patient survival <xref ref-type="bibr" rid="scirp.146216-1">
     [1]
    </xref>-<xref ref-type="bibr" rid="scirp.146216-5">
     [5]
    </xref>. However, a meta-analysis suggests that US-guided AVF cannulation, when performed by renal nurses, may result in a higher successful cannulation rate and reduced complications such as hematoma, oozing blood, and infiltration compared to the conventional blind needling method <xref ref-type="bibr" rid="scirp.146216-6">
     [6]
    </xref>. Pharmacotherapeutic–mechanical thrombolysis showed promising outcomes, resulting in many centers adopting an endovascular-first approach <xref ref-type="bibr" rid="scirp.146216-7">
     [7]
    </xref>.</p>
   <p>The main complications encountered are thrombosis, stenosis, false aneurysms, hemorrhage, hyperflow, and primary failure. These complications are often linked to inadequate monitoring, inappropriate technical procedures or clinical factors such as diabetes, anemia or coagulation disorders <xref ref-type="bibr" rid="scirp.146216-8">
     [8]
    </xref>-<xref ref-type="bibr" rid="scirp.146216-12">
     [12]
    </xref>. Their management remains a challenge in resource-limited settings, due to a lack of specialized equipment (Doppler ultrasound, angioplasty, vascular surgery), a lack of continuing education, and the absence of standardized protocols. In sub-Saharan Africa, very few patients begin dialysis with an arteriovenous fistula <xref ref-type="bibr" rid="scirp.146216-13">
     [13]
    </xref> <xref ref-type="bibr" rid="scirp.146216-14">
     [14]
    </xref>.</p>
   <p>To date, few local studies have exhaustively documented the nature and frequency of AVF complications in Niger or the modalities of their management. It is in this context that we initiated this prospective study in the nephrology department of the Hôpital National Amirou Boubacar Diallo in Niamey, with the main objective of describing the complications of AVF in chronic haemodialysis patients and assessing their management in our context.</p>
  </sec><sec id="s2">
   <title>2. Methodology</title>
   <sec id="s2_1">
    <title>2.1. Type and Scope of Study</title>
    <p>This is a prospective, descriptive and analytical study conducted over a 12-month period, from August 1, 2023 to July 31, 2024, in the nephrology-hemodialysis department of the Hôpital National Amirou Boubacar Diallo (HNABD) in Niamey, Niger.</p>
   </sec>
   <sec id="s2_2">
    <title>2.2. Study Population</title>
    <p>All chronic hemodialysis patients with an arteriovenous fistula (AVF), functional or not, who agreed to participate in the study were included.</p>
    <p>Inclusion criteria were:</p>
    <p>Non-inclusion criteria included:</p>
   </sec>
   <sec id="s2_3">
    <title>2.3. Data Collected</title>
    <p>Data were collected using a standardized form including (<xref ref-type="table" rid="table1">
      Table 1
     </xref>):</p>
    <table-wrap id="table1">
     <label>
      <xref ref-type="table" rid="table1">
       Table 1
      </xref></label>
     <caption>
      <title>
       <xref ref-type="bibr" rid="scirp.146216-"></xref>Table 1. Clinical and demographic characteristics of included patients.</title>
     </caption>
     <table class="MsoTableGrid custom-table" border="0" cellspacing="0" cellpadding="0"> 
      <tr> 
       <td class="custom-bottom-td acenter" width="50.00%"><p style="text-align:center">Variables</p></td> 
       <td class="custom-bottom-td acenter" width="50.00%"><p style="text-align:center">Values</p></td> 
      </tr> 
      <tr> 
       <td class="custom-top-td acenter" width="50.00%"><p style="text-align:center">Total number of patients included</p></td> 
       <td class="custom-top-td acenter" width="50.00%"><p style="text-align:center">126</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="50.00%"><p style="text-align:center">Mean age (± standard deviation)</p></td> 
       <td class="acenter" width="50.00%"><p style="text-align:center">46 years ± 14 years</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="50.00%"><p style="text-align:center">Predominant age range</p></td> 
       <td class="acenter" width="50.00%"><p style="text-align:center">40 years - 49 years (30.2%)</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="50.00%"><p style="text-align:center">Male sex</p></td> 
       <td class="acenter" width="50.00%"><p style="text-align:center">65.9% (n = 83)</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="50.00%"><p style="text-align:center">Hypertension</p></td> 
       <td class="acenter" width="50.00%"><p style="text-align:center">95.2% (n = 120)</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="50.00%"><p style="text-align:center">Diabetes</p></td> 
       <td class="acenter" width="50.00%"><p style="text-align:center">11.1% (n = 14)</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="50.00%"><p style="text-align:center">Chronic glomerulonephritis</p></td> 
       <td class="acenter" width="50.00%"><p style="text-align:center">34.9% (n = 44)</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="50.00%"><p style="text-align:center">Mean duration of hemodialysis</p></td> 
       <td class="acenter" width="50.00%"><p style="text-align:center">36.1 months ± 25.2 months</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="50.00%"><p style="text-align:center">Hemodialysis sessions per week</p></td> 
       <td class="acenter" width="50.00%"><p style="text-align:center">2 sessions for 96.0% of patients</p></td> 
      </tr> 
     </table>
    </table-wrap>
   </sec>
   <sec id="s2_4">
    <title>2.4. Diagnostic Tools and Monitoring</title>
    <p>Each patient underwent a complete clinical examination, carried out in the dialysis room by the medical team. Doppler ultrasound of the AVF was performed on the ward for patients who had access to it, using a Mindray device with a high-frequency linear probe.</p>
    <p>This study was performed using a Mindray ultrasound machine.</p>
    <p>The Doppler ultrasound examination follows a specific methodology:</p>
    <p>Doppler ultrasound allowed us to measure blood flow and obtain a precise anatomical and hemodynamic analysis of arteriovenous fistulas, particularly to detect venous hypoperfusion or hyperperfusion, stenosis, false aneurysms, or thrombosis (<xref ref-type="table" rid="table2">
      Table 2
     </xref>).</p>
    <p>The quality criteria for an arteriovenous fistula were divided into two groups:</p>
    <table-wrap id="table2">
     <label>
      <xref ref-type="table" rid="table2">
       Table 2
      </xref></label>
     <caption>
      <title>
       <xref ref-type="bibr" rid="scirp.146216-"></xref>Table 2. AVF types and anatomical characteristics.</title>
     </caption>
     <table class="MsoTableGrid custom-table" border="0" cellspacing="0" cellpadding="0"> 
      <tr> 
       <td class="custom-bottom-td acenter" width="33.33%"><p style="text-align:center">AVF Characteristics</p></td> 
       <td class="custom-bottom-td acenter" width="33.33%"><p style="text-align:center">Frequency (n)</p></td> 
       <td class="custom-bottom-td acenter" width="33.34%"><p style="text-align:center">Percentage (%)</p></td> 
      </tr> 
      <tr> 
       <td class="custom-top-td acenter" width="33.33%"><p style="text-align:center">Type of native AVF</p></td> 
       <td class="custom-top-td acenter" width="33.33%"><p style="text-align:center">121</p></td> 
       <td class="custom-top-td acenter" width="33.34%"><p style="text-align:center">99.2</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="33.33%"><p style="text-align:center">Prosthetic AVF</p></td> 
       <td class="acenter" width="33.33%"><p style="text-align:center">1</p></td> 
       <td class="acenter" width="33.34%"><p style="text-align:center">0.8</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="33.33%"><p style="text-align:center">Radiocephalic AVF</p></td> 
       <td class="acenter" width="33.33%"><p style="text-align:center">77</p></td> 
       <td class="acenter" width="33.34%"><p style="text-align:center">61.1</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="33.33%"><p style="text-align:center">Humerocephalic AVF</p></td> 
       <td class="acenter" width="33.33%"><p style="text-align:center">49</p></td> 
       <td class="acenter" width="33.34%"><p style="text-align:center">38.9</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="33.33%"><p style="text-align:center">Distal left location</p></td> 
       <td class="acenter" width="33.33%"><p style="text-align:center">64</p></td> 
       <td class="acenter" width="33.34%"><p style="text-align:center">50.8</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="33.33%"><p style="text-align:center">Average lifespan of AVFs</p></td> 
       <td class="acenter" width="33.33%"><p style="text-align:center">-</p></td> 
       <td class="acenter" width="33.34%"><p style="text-align:center">33.1 months ± 24.8 months</p></td> 
      </tr> 
     </table>
    </table-wrap>
   </sec>
   <sec id="s2_5">
    <title>2.5. Definitions of Operational Variables</title>
   </sec>
   <sec id="s2_6">
    <title>2.6. Ethical and Professional Considerations</title>
    <p>Our study was conducted after submitting a research authorization request to the Dean of the Faculty of Health Sciences (FSS) at Abdou Moumouni University (UAM). We then obtained approval from the Dean of the FSS and the Director of the HNABD.</p>
    <p>The informed consent of each patient included in the study was obtained.</p>
   </sec>
   <sec id="s2_7">
    <title>2.7. Statistical Analysis</title>
    <p>Data were entered using Microsoft Excel 2013 and analyzed with Epi Info version 7.2.5.0 and SPSS version 25.0.</p>
   </sec>
  </sec><sec id="s3">
   <title>3. Results</title>
   <sec id="s3_1">
    <title>3.1. General Patient Characteristics</title>
    <p>Of a total of 225 patients on chronic hemodialysis during the study period, 126 were included, representing an inclusion rate of 56%.</p>
    <p>The mean age of the patients was 46 years ± 14 years (extremes: 13 to 70 years). The most common age group was 40 to 49 (30.2%). Males predominated, accounting for 65.9% of cases (n = 83), giving an M/F sex ratio of 1.93.</p>
    <p>Hypertension was the most frequent comorbidity (95.2%, n = 120), followed by diabetes (11.1%) and heart failure (10.3%). Regarding the etiology of CKD, chronic glomerulonephritis was the most common (34.9%), followed by undetermined nephropathy (32.5%) and hypertensive nephropathy (22.2%).</p>
    <p>The mean duration of hemodialysis treatment was 36.1 months ± 25.2 months (extremes: 3 to 204 months). The vast majority of patients (96%) received 2 weekly sessions.</p>
   </sec>
   <sec id="s3_2">
    <title>3.2. Arteriovenous Fistula Characteristics</title>
    <p>Native arteriovenous fistula (AVF) was the predominant vascular approach, found in 99.2% of cases (n = 121). Only one patient had a prosthetic fistula.</p>
    <p>Fistulas were predominantly radiocephalic (61.1%, n = 77), followed by humerocephalic (38.9%, n = 49). The most frequent site of creation was the distal left arm (50.8%), followed by the proximal left arm (30.9%).</p>
    <p>
     <xref ref-type="bibr" rid="scirp.146216-"></xref>Right laterality was dominant in 81.8% of cases. The mean lifespan of the AVFs was 33.1 months ± 24.8 months (extremes: 2 to 196 months).</p>
   </sec>
   <sec id="s3_3">
    <title>3.3. Clinical Data on Examination</title>
    <p>On examination, more than half of AVFs were clinically normal (55.6%). The most frequent abnormalities were:</p>
    <p>Thrill was present and satisfactory (&gt;10 cm) in 80.9% of cases.</p>
    <p>Biologically, the majority of patients were anemic, with mild to moderate anemia in 86.7% of cases.</p>
   </sec>
   <sec id="s3_4">
    <title>3.4. Doppler Ultrasound Monitoring</title>
    <p>Doppler ultrasound was performed in 51.6% of patients (n = 65). Of these, the examination was normal in 40% (n = 26).</p>
   </sec>
   <sec id="s3_5">
    <title>3.5. AVF Complications (<xref ref-type="table" rid="table3">
      Table 3
     </xref>)</title>
    <table-wrap id="table3">
     <label>
      <xref ref-type="table" rid="table3">
       Table 3
      </xref></label>
     <caption>
      <title>
       <xref ref-type="bibr" rid="scirp.146216-"></xref>Table 3. Observed complications, treatments, and evolution.</title>
     </caption>
     <table class="MsoTableGrid custom-table" border="0" cellspacing="0" cellpadding="0"> 
      <tr> 
       <td class="custom-bottom-td acenter" width="23.21%"><p style="text-align:center">Complication</p></td> 
       <td class="custom-bottom-td acenter" width="19.19%"><p style="text-align:center">Frequency</p><p style="text-align:center">(n)</p></td> 
       <td class="custom-bottom-td acenter" width="19.20%"><p style="text-align:center">Percentage</p><p style="text-align:center">(%)</p></td> 
       <td class="custom-bottom-td acenter" width="19.19%"><p style="text-align:center">Treatment Received (%)</p></td> 
       <td class="custom-bottom-td acenter" width="19.20%"><p style="text-align:center">Favourable Outcome (%)</p></td> 
      </tr> 
      <tr> 
       <td class="custom-top-td acenter" width="23.21%"><p style="text-align:center">False aneurysm</p></td> 
       <td class="custom-top-td acenter" width="19.19%"><p style="text-align:center">25</p></td> 
       <td class="custom-top-td acenter" width="19.20%"><p style="text-align:center">46.3</p></td> 
       <td class="custom-top-td acenter" width="19.19%"><p style="text-align:center">40.0</p></td> 
       <td class="custom-top-td acenter" width="19.20%"><p style="text-align:center">36.0</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="23.21%"><p style="text-align:center">Primary failure</p></td> 
       <td class="acenter" width="19.19%"><p style="text-align:center">12</p></td> 
       <td class="acenter" width="19.20%"><p style="text-align:center">22.2</p></td> 
       <td class="acenter" width="19.19%"><p style="text-align:center">16.7</p></td> 
       <td class="acenter" width="19.20%"><p style="text-align:center">33.3</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="23.21%"><p style="text-align:center">Thrombosis</p></td> 
       <td class="acenter" width="19.19%"><p style="text-align:center">10</p></td> 
       <td class="acenter" width="19.20%"><p style="text-align:center">18.5</p></td> 
       <td class="acenter" width="19.19%"><p style="text-align:center">76.9</p></td> 
       <td class="acenter" width="19.20%"><p style="text-align:center">30.8</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="23.21%"><p style="text-align:center">Stenosis</p></td> 
       <td class="acenter" width="19.19%"><p style="text-align:center">5</p></td> 
       <td class="acenter" width="19.20%"><p style="text-align:center">9.3</p></td> 
       <td class="acenter" width="19.19%"><p style="text-align:center">-</p></td> 
       <td class="acenter" width="19.20%"><p style="text-align:center">-</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="23.21%"><p style="text-align:center">Hyperflow</p></td> 
       <td class="acenter" width="19.19%"><p style="text-align:center">5</p></td> 
       <td class="acenter" width="19.20%"><p style="text-align:center">9.3</p></td> 
       <td class="acenter" width="19.19%"><p style="text-align:center">-</p></td> 
       <td class="acenter" width="19.20%"><p style="text-align:center">-</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="23.21%"><p style="text-align:center">Hemorrhage</p></td> 
       <td class="acenter" width="19.19%"><p style="text-align:center">3</p></td> 
       <td class="acenter" width="19.20%"><p style="text-align:center">5.6</p></td> 
       <td class="acenter" width="19.19%"><p style="text-align:center">-</p></td> 
       <td class="acenter" width="19.20%"><p style="text-align:center">-</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="23.21%"><p style="text-align:center">Total patients treated</p></td> 
       <td class="acenter" width="19.19%"><p style="text-align:center">13</p></td> 
       <td class="acenter" width="19.20%"><p style="text-align:center">24.1</p></td> 
       <td class="acenter" width="19.19%"><p style="text-align:center">-</p></td> 
       <td class="acenter" width="19.20%"><p style="text-align:center">38.5% (all patients)</p></td> 
      </tr> 
     </table>
    </table-wrap>
    <p>Complications were observed in 42.9% of patients (n = 54). The main complications were</p>
   </sec>
   <sec id="s3_6">
    <title>3.6. Management of Complications</title>
    <p>Of patients presenting complications, 24.1% (n = 13) received treatment. Treatment was drug-based in 92.3% of cases (n = 12), and mainly involved:</p>
    <p>Thrombosis was the complication requiring the most treatment (76.9% of cases treated).</p>
    <p>Post-treatment outcome was favorable in 38.5% of cases, while loss of AVF was observed in 61.5% of treated cases.</p>
    <p>This situation can be explained by a lack of technical facilities. In most cases, fistulas are closed by surgeons in the event of fistula rupture or significant hyperflow leading to heart failure.</p>
   </sec>
   <sec id="s3_7">
    <title>3.7. Statistical Analysis</title>
    <p>The statistically significant relationships identified were as follows:</p>
    <p>In multivariate logistic regression, age, diabetes, age at dialysis, hemoglobin, anemia, and female sex remain independent predictors (<xref ref-type="fig" rid="fig1">
      Figure 1
     </xref>).</p>
    <fig id="fig1" position="float">
     <label>Figure 1</label>
     <caption>
      <title>
       <xref ref-type="bibr" rid="scirp.146216-"></xref>Figure 1. 1.35% of factors such as age, diabetes, and age at dialysis explain the occurrence of anemia (adjusted R-squared = 1.35%). The model is statistically very significant (p &lt; 0.05), p = 0.023.</title>
     </caption>
     <graphic mimetype="image" position="float" xlink:type="simple" xlink:href="https://html.scirp.org/file/2070702-rId17.jpeg?20250930094958" />
    </fig>
    <p>In multivariate logistic regression, age, diabetes, age at dialysis, and gender remain independent predictors (<xref ref-type="fig" rid="fig2">
      Figure 2
     </xref>).</p>
    <fig id="fig2" position="float">
     <label>Figure 2</label>
     <caption>
      <title>
       <xref ref-type="bibr" rid="scirp.146216-"></xref>Figure 2. 5.66% of factors such as age, diabetes, and dialysis age explain the link to gender (adjusted R-squared = 5.66%). The model is statistically highly significant (p &lt; 0.05), p = 0.017.</title>
     </caption>
     <graphic mimetype="image" position="float" xlink:type="simple" xlink:href="https://html.scirp.org/file/2070702-rId18.jpeg?20250930094958" />
    </fig>
   </sec>
  </sec><sec id="s4">
   <title>4. Discussion</title>
   <sec id="s4_1">
    <title>4.1. Predominance of Native AVF</title>
    <p>In our study, the native arteriovenous fistula was the most commonly used vascular approach (99.2%), with a predominance of radio-cephalic AVFs (61.1%). This practice is in line with international recommendations, which favor native AVF as the first choice of vascular approach due to its longevity, low infection rate, and reduced cost <xref ref-type="bibr" rid="scirp.146216-1">
      [1]
     </xref> <xref ref-type="bibr" rid="scirp.146216-2">
      [2]
     </xref>.</p>
    <p>Our results concur with those of Karar et al. in Algeria <xref ref-type="bibr" rid="scirp.146216-15">
      [15]
     </xref>, who reported a similar proportion of native AVFs, and confirm the rarity of using prosthetic grafts in resource-limited countries, due to economic constraints and an insufficient technical platform.</p>
   </sec>
   <sec id="s4_2">
    <title>4.2. High Frequency of Complications</title>
    <p>The frequency of complications in our series (42.9%) is high, but remains consistent with African data reporting significant morbidity associated with AVFs <xref ref-type="bibr" rid="scirp.146216-15">
      [15]
     </xref>-<xref ref-type="bibr" rid="scirp.146216-17">
      [17]
     </xref>. This frequency may be linked to inadequate monitoring, repeated puncture at the same site, the absence of a structured Doppler follow-up program, and insufficient training of nursing staff.</p>
   </sec>
   <sec id="s4_3">
    <title>4.3. Complication Profile</title>
    <p>Contrary to many studies in the literature, in which thrombosis is the most frequent complication <xref ref-type="bibr" rid="scirp.146216-16">
      [16]
     </xref> <xref ref-type="bibr" rid="scirp.146216-17">
      [17]
     </xref>, our series shows a predominance of false aneurysms (46.3%). This specificity could be explained by repeated punctures at the same site, poor needling technique, and lack of systematic rotation of puncture sites, exacerbated by the absence of prior ultrasound identification.</p>
    <p>Thrombosis, although in 3rd place, remains a dreaded complication, occurring in 18.5% of cases. In our study, thrombosis was significantly associated with anemia (p = 0.03) and female gender (p = 0.04). This latter finding is in line with several publications suggesting a greater susceptibility of women to thrombosis, in relation to vascular caliber and hormonal factors <xref ref-type="bibr" rid="scirp.146216-17">
      [17]
     </xref>-<xref ref-type="bibr" rid="scirp.146216-21">
      [21]
     </xref>.</p>
   </sec>
   <sec id="s4_4">
    <title>4.4. Primary Failure and Risk Factors</title>
    <p>Primary failure accounted for 22.2% of complications. Contrary to some publications <xref ref-type="bibr" rid="scirp.146216-18">
      [18]
     </xref> <xref ref-type="bibr" rid="scirp.146216-19">
      [19]
     </xref>, we found no significant association between primary failure and diabetes (p = 0.15), although this comorbidity is known to favor diffuse arterial damage and mediacalcosis, which impede AVF maturation. This result may be linked to the modest size of our sample or to an underestimation of associated vascular lesions.</p>
   </sec>
   <sec id="s4_5">
    <title>4.5. Correlations between Lifespan and Degenerative Lesions</title>
    <p>We found a significant association between prolonged AVF lifespan and certain degenerative complications such as stenosis (p = 0.0005), false aneurysm (p = 0.0001), and hyperflow (p = 0.0001). These results reinforce the idea that prolonged exposure to high arterial pressures and repeated punctures induces vascular structural remodeling <xref ref-type="bibr" rid="scirp.146216-20">
      [20]
     </xref>.</p>
   </sec>
   <sec id="s4_6">
    <title>4.6. Monitoring and Imaging Still Inadequate</title>
    <p>Doppler ultrasonography was performed in only 51.6% of patients, despite being a fundamental tool for detecting silent or sub-clinical complications <xref ref-type="bibr" rid="scirp.146216-1">
      [1]
     </xref> <xref ref-type="bibr" rid="scirp.146216-3">
      [3]
     </xref>. Its limited access reflects the structural constraints of our healthcare system. The development of a systematic Doppler screening strategy, even if targeted, could significantly improve the early detection and longevity of AVFs.</p>
   </sec>
   <sec id="s4_7">
    <title>4.7. Treatment Modalities and Outcome</title>
    <p>Most complications were treated with drugs (92.3%), mainly anti-inflammatories and anticoagulants. This finding is in line with data from Baldé et al. in Guinea <xref ref-type="bibr" rid="scirp.146216-17">
      [17]
     </xref>. However, this approach often remains palliative. The failure rate (loss of AVF in 61.5% of cases treated) underlines the need to integrate vascular surgery and interventional radiology into the local therapeutic arsenal.</p>
   </sec>
   <sec id="s4_8">
    <title>4.8. Study Limitations</title>
    <p>This study has certain limitations:</p>
   </sec>
  </sec><sec id="s5">
   <title>5. Conclusions</title>
   <p>Arteriovenous fistulas (AVFs) remain the preferred vascular approach for chronic hemodialysis in Niger, despite a context of limited resources. Our study highlights a high frequency of complications, affecting nearly 43% of patients, with an unusual predominance of false aneurysms, followed by primary failure and thrombosis. These complications seriously compromise the quality and continuity of care.</p>
   <p>Doppler monitoring remains inaccessible, and management remains largely drug-based, with a high rate of functional loss of AVFs. Factors such as anemia, duration of AVF evolution, female gender, and lack of standardized protocols contribute to this situation.</p>
   <p>These results underline the need to reinforce clinical and paraclinical monitoring of AVFs, to structure team training, and to improve access to surgical or interventional therapeutic alternatives.</p>
  </sec>
 </body><back>
  <ref-list>
   <title>References</title>
   <ref id="scirp.146216-ref1">
    <label>1</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Al-Jaishi, A.A., Liu, A.R., Lok, C.E., Zhang, J.C. and Moist, L.M. (2016) Complications of the Arteriovenous Fistula: A Systematic Review. Journal of the American Society of Nephrology, 28, 1839-1850. &gt;https://doi.org/10.1681/asn.2016040412
    </mixed-citation>
   </ref>
   <ref id="scirp.146216-ref2">
    <label>2</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Vascular Access 2006 Work Group (2006) Clinical Practice Guidelines for Vascular Access. American Journal of Kidney Diseases, 48, S176-S247.
    </mixed-citation>
   </ref>
   <ref id="scirp.146216-ref3">
    <label>3</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Tordoir, J., Canaud, B., Haage, P., Konner, K., Basci, A., Fouque, D., et al. (2007) EBPG on Vascular Access. Nephrology Dialysis Transplantation, 22, ii88-ii117. &gt;https://doi.org/10.1093/ndt/gfm021
    </mixed-citation>
   </ref>
   <ref id="scirp.146216-ref4">
    <label>4</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Lok, C.E., Sontrop, J.M., Tomlinson, G., Rajan, D., Cattral, M., Oreopoulos, G., et al. (2013) Cumulative Patency of Contemporary Fistulas versus Grafts (2000-2010). Clinical Journal of the American Society of Nephrology, 8, 810-818. &gt;https://doi.org/10.2215/cjn.00730112
    </mixed-citation>
   </ref>
   <ref id="scirp.146216-ref5">
    <label>5</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Huijbregts, H.J.T., Bots, M.L., Wittens, C.H.A., Schrama, Y.C., Moll, F.L. and Blankestijn, P.J. (2008) Hemodialysis Arteriovenous Fistula Patency Revisited: Results of a Prospective, Multicenter Initiative. Clinical Journal of the American Society of Nephrology, 3, 714-719. &gt;https://doi.org/10.2215/cjn.02950707
    </mixed-citation>
   </ref>
   <ref id="scirp.146216-ref6">
    <label>6</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Chan, A.H.M. and Lam, A.H.Y. (2024) Effectiveness of Ultrasound-Guided Arteriovenous Fistulas Cannulation in Difficult Hemodialysis Arteriovenous Access: A Meta-Analysis of Randomised Controlled Trials. Health, 16, 994-1012. &gt;https://doi.org/10.4236/health.2024.1611068
    </mixed-citation>
   </ref>
   <ref id="scirp.146216-ref7">
    <label>7</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Chia, C.K.A. and Tay, H.T. (2024) Endovascular Salvage of a Chronically Thrombosed Hemodialysis Arteriovenous Fistula. Journal of Vascular Surgery Cases, Innovations and Techniques, 10, Article ID: 101472. &gt;https://doi.org/10.1016/j.jvscit.2024.101472
    </mixed-citation>
   </ref>
   <ref id="scirp.146216-ref8">
    <label>8</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Jindal, K., Chan, C.T., Deziel, C., Hirsch, D., Soroka, S.D., Tonelli, M. and Culleton, B.F. (2006) Canadian Society of Nephrology Committee for Clinical Practice Guidelines: Hemodialysis Clinical Practice Guidelines for the Canadian Society of Nephrology. Journal of the American Society of Nephrology, 17, S1-S27.
    </mixed-citation>
   </ref>
   <ref id="scirp.146216-ref9">
    <label>9</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Tonelli, M., Klarenbach, S., Jindal, K. and Manns, B. (2006) Economic Implications of Screening Strategies in Arteriovenous Fistulae. Kidney International, 69, 2219-2226. &gt;https://doi.org/10.1038/sj.ki.5000151
    </mixed-citation>
   </ref>
   <ref id="scirp.146216-ref10">
    <label>10</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Lee, H., Manns, B., Taub, K., Ghali, W.A., Dean, S., Johnson, D., et al. (2002) Cost Analysis of Ongoing Care of Patients with End-Stage Renal Disease: The Impact of Dialysis Modality and Dialysis Access. American Journal of Kidney Diseases, 40, 611-622. &gt;https://doi.org/10.1053/ajkd.2002.34924
    </mixed-citation>
   </ref>
   <ref id="scirp.146216-ref11">
    <label>11</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Manns, B., Tonelli, M., Yilmaz, S., Lee, H., Laupland, K., Klarenbach, S., et al. (2005) Establishment and Maintenance of Vascular Access in Incident Hemodialysis Patients: A Prospective Cost Analysis. Journal of the American Society of Nephrology, 16, 201-209. &gt;https://doi.org/10.1681/asn.2004050355
    </mixed-citation>
   </ref>
   <ref id="scirp.146216-ref12">
    <label>12</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Ravani, P., Palmer, S.C., Oliver, M.J., Quinn, R.R., MacRae, J.M., Tai, D.J., et al. (2013) Associations between Hemodialysis Access Type and Clinical Outcomes: A Systematic Review. Journal of the American Society of Nephrology, 24, 465-473. &gt;https://doi.org/10.1681/asn.2012070643
    </mixed-citation>
   </ref>
   <ref id="scirp.146216-ref13">
    <label>13</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Keita, N., Sakho, B., Faye, M., Diagne, S., Dieng, A., Ba, M., et al. (2021) Délai de création de la première fistule artério-veineuse pour hémodialyseau sénégal. Dakar Medical, 67, 133-137. &gt;https://doi.org/10.61585/pud-dkm-v67207
    </mixed-citation>
   </ref>
   <ref id="scirp.146216-ref14">
    <label>14</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Traoré, A., Bangoura, S., Camara, M.L.T., Tolno, A., Barry, K.M.B., Diallo, A.Y. and Kaba, M.L. (2024) Complications des fistules artérioveineuses (FAV) chez les Hémodialysés au Centre National d’Hémodialyse de Donka. Guinée Médicale, 110, 48-50.
    </mixed-citation>
   </ref>
   <ref id="scirp.146216-ref15">
    <label>15</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Karar, B., Smili, A. and Salem, B. (2024) Prise en charge des complications des fistules artérioveineuses pour hémodialyse chronique (expérience du service). JMV-Journal de Médecine Vasculaire, 49, 52. &gt;https://doi.org/10.1016/j.jdmv.2023.12.040
    </mixed-citation>
   </ref>
   <ref id="scirp.146216-ref16">
    <label>16</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Jiber, H., Zrihni, Y., Zaghloul, R., Hajji, R., Zizi, O. and Bouarhroum, A. (2015) Prise en charge des complications des fistules artério-veineuses pour hémodialyse chronique. Pan African Medical Journal, 20, Article 202. &gt;https://doi.org/10.11604/pamj.2015.20.202.3617
    </mixed-citation>
   </ref>
   <ref id="scirp.146216-ref17">
    <label>17</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Baldé, M.S., Boubacar, A., Diakité, F., Traoré, M., Sandouno, A. and Kaba, M.L. (2013) Complications des fistules artério-veineuses chez les patients hémodialysés au centre National d’hémodialyse de Donka [Artriovenous Fistula Complication in Hemodialysed Patient at National Hospital of Donka]. Néphrologie&amp;Thérapeutique, 9, 283-319.
    </mixed-citation>
   </ref>
   <ref id="scirp.146216-ref18">
    <label>18</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Miller, P.E., Tolwani, A., Luscy, C.P., Deierhoi, M.H., Bailey, R., Redden, D.T., et al. (1999) Predictors of Adequacy of Arteriovenous Fistulas in Hemodialysis Patients. Kidney International, 56, 275-280. &gt;https://doi.org/10.1046/j.1523-1755.1999.00515.x
    </mixed-citation>
   </ref>
   <ref id="scirp.146216-ref19">
    <label>19</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Golledge, J., Smith, C.J., Emery, J., Farrington, K. and Thompson, H.H. (1999) Outcome of Primary Radiocephalic Fistula for Haemodialysis. Journal of British Surgery, 86, 211-216. &gt;https://doi.org/10.1046/j.1365-2168.1999.01007.x
    </mixed-citation>
   </ref>
   <ref id="scirp.146216-ref20">
    <label>20</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Rajput, A., Rajan, D.K., Simons, M.E., Sniderman, K.W., Jaskolka, J.D., Beecroft, J.R., et al. (2012) Venous Aneurysms in Autogenous Hemodialysis Fistulas: Is There an Association with Venous Outflow Stenosis? The Journal of Vascular Access, 14, 126-130. &gt;https://doi.org/10.5301/jva.5000111
    </mixed-citation>
   </ref>
   <ref id="scirp.146216-ref21">
    <label>21</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Kharchafi, A., Oualim, Z., Amezyane, T., Mahassin, F., Ghafir, D., Ohayon, V., et al. (2002) Maladie de Biermer et thrombose veineuse. À propos de deux observations. La Revue de Médecine Interne, 23, 563-566. &gt;https://doi.org/10.1016/s0248-8663(02)00613-6
    </mixed-citation>
   </ref>
  </ref-list>
 </back>
</article>